前臨床CROの世界市場:サービス別(生体分析及びDMPK研究、毒性試験)、最終用途別(バイオ製薬企業、医療機器企業)

◆英語タイトル:Preclinical CRO Market Size, Share & Trends Analysis Report By Services (Bioanalysis & DMPK Studies, Toxicology Testing), By End Use (Biopharmaceutical Companies, Medical Device Companies), And Segment Forecasts, 2020 - 2027
◆商品コード:GV20MY065
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年3月30日
◆ページ数:100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥624,750見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥729,750見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥939,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、前臨床CROの世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、サービス別(生体分析及びDMPK研究、毒性試験、その他)分析、最終用途別(バイオ製薬企業、政府および学術機関、医療機器企業)分析、地域別分析、競争分析などの構成でお届けいたします。
・調査手法・範囲
・エグゼクティブサマリー
・市場要因・動向・範囲
・前臨床CROの世界市場:サービス別(生体分析及びDMPK研究、毒性試験、その他)
・前臨床CROの世界市場:最終用途別(バイオ製薬企業、政府および学術機関、医療機器企業)
・前臨床CROの世界市場:地域別
・競争分析
【レポートの概要】

The global preclinical CRO market size is expected to reach USD 7.8 billion by 2027, registering a CAGR of 8.3% over the forecast period, according to a new report by Grand View Research, Inc. The market is expected to show lucrative growth due to increasing R&D expenditure and rising outsourcing trend, which is expected to increase the demand for preclinical trials in the future. Whereas rise in number of complex drugs entering clinical trials and increasing R&D expenses are some of the factors responsible for the preclinical Contract Research Organization (CRO) growth. Increasing prices and changes in reimbursement policies are also anticipated to boost the in emerging countries such as India and China.

Increasing number of new entrants in market is anticipated to help the market to grow during the forecast period. Various companies are focusing on research and development of new drugs and therefore are outsourcing these activities to launch efficient CRO services in the market.

Further key findings from the report suggest:

• Toxicology testing held the largest share in the service segment in 2019 due to increasing trend of outsourcing, especially in emerging countries

• Bioanalysis is expected to grow with the highest CAGR of 8.8% over the forecast period

• North America dominates the market with the largest share of 47.5% in 2019 owing to advanced healthcare infrastructure in the region

• The Asia Pacific region is projected to witness the fastest growth during the forecast period owing to government support in development of outsourcing hubs along with availability of skilled practitioners

• Some of the key preclinical CRO market players are Envigo Corporation, MPI research, and Eurofins Scientific.

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Service
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and end-use scopes to conclude on the market size
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Preclinical CRO Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Service
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Suring number of drugs in preclinical phases
3.4.1.2. Economies of production and scale
3.4.1.3. Increasing R&D expenditure
3.4.2. Market Restraint Analysis
3.4.2.1. High labor cost
3.4.2.2. Stringent regulatory policies
3.4.3. Industry Challenges
3.4.3.1. Managing the relationships
3.5. Preclinical CRO: Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Technology Landscape
3.5.2.5. Legal Landscape
3.5.3. Major Deals & Strategic Alliances Analysis
Chapter 4. Preclinical CRO Market : Segment Analysis, by Services, 2016 – 2027 (USD Million)
4.1. Definitions & Scope
4.2. Product market share analysis, 2019 & 2027
4.3. Segment Dashboard
4.4. Global Preclinical CRO Market, by services, 2016 to 2027
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
4.5.1. Bioanalysis and DMPK studies
4.5.2. Toxicology testing
4.5.3. Others
Chapter 5. Preclinical CRO Market : Segment Analysis, By End-use, 2016 – 2027 (USD Million)
5.1. Definitions & Scope
5.2. End-use market share analysis, 2019 & 2027
5.3. Segment Dashboard
5.4. Global Preclinical CRO market, by end-use, 2016 to 2027
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
5.5.1. Biopharmaceutical companies
5.5.2. Government and academic institutes
5.5.3. Medical device companies
Chapter 6. Preclinical CRO Market : Regional Market Analysis, By Services, 2016 – 2027 (USD Million)
6.1. Definitions & Scope
6.2. Regional Market Share Analysis, 2019 & 2027
6.3. Regional Market Dashboard
6.4. Regional Market Snapshot
6.5. Regional Market Share, 2018
6.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2027:
6.7. North America
6.7.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
6.7.2. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.7.3. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.7.4. U.S.
6.7.4.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.7.4.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.7.5. Canada
6.7.5.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.7.5.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8. Europe
6.8.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
6.8.2. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.3. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.4. Germany
6.8.4.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.4.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.5. U.K.
6.8.5.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.5.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.6. France
6.8.6.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.6.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.7. Italy
6.8.7.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.7.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.8. Spain
6.8.8.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.8.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.9. Netherlands
6.8.9.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.9.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.10. Belgium
6.8.10.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.10.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.11. Switzerland
6.8.11.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.11.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.12. Russia
6.8.12.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.12.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.13. Sweden
6.8.13.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.13.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9. Asia Pacific
6.9.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
6.9.2. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.3. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.4. China
6.9.4.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.4.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.5. Japan
6.9.5.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.5.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.6. India
6.9.6.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.6.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.7. Australia
6.9.7.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.7.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.8. South Korea
6.9.8.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.8.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.9. Malaysia
6.9.9.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.9.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.10. Indonesia
6.9.11. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.12. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.13. Singapore
6.9.14. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.15. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.16. Philippines
6.9.17. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.18. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.19. Thailand
6.9.20. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.21. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.10. Latin America
6.10.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
6.10.2. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.10.3. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.10.4. Brazil
6.10.4.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.10.4.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.10.5. Mexico
6.10.5.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.10.5.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.10.6. Argentina
6.10.6.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.10.6.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.10.7. Colombia
6.10.7.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.10.7.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.10.8. Chile
6.10.8.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.10.8.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.11. Middle East and Africa
6.11.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
6.11.2. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.11.3. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.11.4. South Africa
6.11.4.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.11.4.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.11.5. Saudi Arabia
6.11.5.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.11.5.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.11.6. UAE
6.11.6.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.11.6.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.11.7. Israel
6.11.7.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.11.7.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.11.8. Egypt
6.11.8.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.11.8.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
Chapter 7. Preclinical CRO Market – Competitive Analysis
7.1. Key companies profiled
7.1.1. Envigo Corporation
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. MPI research
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Eurofins Scientific
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. PRA Health Sciences, Inc
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Wuxi AppTec
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. Medpace, Inc.
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Pharmaceutical Product Development (PPD), LLC
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. PARAXEL International Corporation
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. ICON Plc.
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. Laboratory Corporation of America, Inc.
7.1.10.1. Company Overview
7.1.10.2. Financial Performance
7.1.10.3. Product Benchmarking
7.1.10.4. Strategic Initiatives

List of Tables

TABLE 1 Facial Recognition Market Outlook
TABLE 2 Global Facial recognition market, 2016 - 2027 (USD Million)
TABLE 3 Global Facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 4 Global Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 5 Global Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 6 Global Facial recognition market by end-use, (USD Million), 2016 - 2027
TABLE 7 Facial recognition - Key market driver impact
TABLE 8 Facial recognition - Key market restraint impact
TABLE 9 List of key market players
TABLE 10 Global 2D facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 11 Global 3D facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 12 Global facial analytics facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 13 Global emotion recognition facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 14 Global attendance tracking and monitoring facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 15 Global access control facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 16 Global security & surveillance facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 17 Global others facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 18 Global retail & e-commerce facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 19 Global media & entertainment facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 20 Global BFSI facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 21 Global automobile & transportation facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 22 Global telecom & IT facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 23 Global government facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 24 Global healthcare facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 25 Global others facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 26 North America Facial recognition market, 2016 - 2027 (USD Million)
TABLE 27 North America Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 28 North America Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 29 North America Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 30 U.S. Facial recognition market, 2016 - 2027 (USD Million)
TABLE 31 U.S. Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 32 U.S. Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 33 U.S. Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 34 Canada Facial recognition market, 2016 - 2027 (USD Million)
TABLE 35 Canada Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 36 Canada Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 37 Canada Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 38 Mexico Facial recognition market, 2016 - 2027 (USD Million)
TABLE 39 Mexico Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 40 Mexico Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 41 Mexico Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 42 Europe Facial recognition market, 2016 - 2027 (USD Million)
TABLE 43 Europe Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 44 Europe Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 45 Europe Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 46 Germany. Facial recognition market, 2016 - 2027 (USD Million)
TABLE 47 Germany Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 48 Germany Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 49 Germany Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 50 U.K. Facial recognition market, 2016 - 2027 (USD Million)
TABLE 51 U.K. Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 52 U.K. Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 53 U.K. Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 54 France Facial recognition market, 2016 - 2027 (USD Million)
TABLE 55 France Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 56 France Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 57 France Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 58 Asia Pacific Facial recognition market, 2016 - 2027 (USD Million)
TABLE 59 Asia Pacific Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 60 Asia Pacific Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 61 Asia Pacific Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 62 China Facial recognition market, 2016 - 2027 (USD Million)
TABLE 63 China Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 64 China Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 65 China Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 66 Japan Facial recognition market, 2016 - 2027 (USD Million)
TABLE 67 Japan Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 68 Japan Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 69 Japan Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 70 India Facial recognition market, 2016 - 2027 (USD Million)
TABLE 71 India Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 72 India Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 73 India Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 74 South America Facial recognition market, 2016 - 2027 (USD Million)
TABLE 75 South America Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 76 South America Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 77 South America Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 78 Brazil Facial recognition market, 2016 - 2027 (USD Million)
TABLE 79 Brazil Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 80 Brazil Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 81 Brazil Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 82 MEA Facial recognition market, 2016 - 2027 (USD Million)
TABLE 83 MEA Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 84 MEA Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 85 MEA Facial recognition market by end-use, 2016 - 2027 (USD Million)

List of Figures

FIG. 1 Research process
FIG. 2 Market Formulation
FIG. 3 Market segmentation & scope
FIG. 4 Global facial recognition market 2016 - 2027 (USD Million)
FIG. 5 Facial recognition market size and growth prospects (USD Million)
FIG. 6 Facial recognition - Value chain analysis
FIG. 7 Market dynamics
FIG. 8 Regional outlook, 2019 & 2027

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[前臨床CROの世界市場:サービス別(生体分析及びDMPK研究、毒性試験)、最終用途別(バイオ製薬企業、医療機器企業)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆